AI Models for Predicting Occult Pleural Dissemination in NSCLC

Brief summary (registry, in English)

Occult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and generally contraindicated for radical surgery. This study aimed to develop and compare the performance of radiomics-based machine learning (ML), deep learning (DL), and fusion models to preoperatively identify occult PDs in NSCLC patients. Patients from three Chinese high-volume medical centers (2016-2023) were retrospectively collected and divided into training, internal test, and external test cohorts. Ten radiomics-based ML models and eight DL models were trained using CT plain scan images at the maximum cross-sectional areas of the primary tumor. Moreover, another two fusion models (prefusion and postfusion) were developed using feature-based and decision-based methods. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were mainly used to compare the predictive performance of the models.

What you commit to

• Study type: Observational
• Participants enrolled: 326
• From 13 Dec 2023 to the primary completion date, 1 Jan 2025
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.